Sergei Polevikov has served as a unique voice in the healthcare tech industry as a result of his contributions in the field of artificial intelligence projects that focus on assisting professionals in dealing with the increasing amount of available data in the medical field. As a co-founder of the health tech firm WellAI, his contributions included the development of machine learning tools that aid in the synthesis of available research in the medical field.
Polevikov’s current projects are inspired by his background and education in quantitative subjects, such as math and data science, and initial professional experience in finance. Polevikov started working in finance as a quantitative analyst in asset management companies, and his duties involved data modeling and market analysis. This phase of his professional life concluded after a federal case of securities fraud in the United States. Polevikov pleaded guilty in 2021 to charges concerning a front-running violation regarding non-public information in trades. Later, he was sentenced to jail, ordered to forfeit cash, and prohibited from participating in the security business. At the conclusion of this episode in his life, he found a fresh start in the healthcare technology industry.
Polevikov co-founded WellAI, a digital health firm that concentrated on the application of machine learning algorithms to medical information and processes. The firm developed an AI-based system aimed at assisting medical professionals in making sense of a vast amount of medical research and scientific literature. During his tenure with the firm, Polevikov held various executive and advisory roles and engaged in various discussions regarding the proper application of AI in a healthcare setting.
Studies related to WellAI were presented during healthcare analytics and technology conferences, which highlight the company’s focus on data-driven solutions and networking. The studies put the company among the startups trying to solve long-standing information management issues in the healthcare industry using natural language processing and machine learning.
Running side by side with his entrepreneurial pursuits, Polevikov has also gained recognition for his writing and commentary on healthcare AI. He is the founder and editor of an online newsletter that interprets and analyzes trends in digital health and artificial intelligence. Instead of arguing against the adoption of AI, his work focuses on progress and collaboration between disciplines and between technologists and healthcare providers. He has suggested that many issues in using AI effectively in healthcare are organizational and economic.
Aside from self-publishing, Polevikov has participated in industry panels and professional discussions on the topics of healthcare analytics, diagnostics, and AI ethics. His contributions usually revolve around system-level aspects such as how AI systems can integrate with current clinical processes and structures. Within the healthcare AI community, Polevikov is seen more as an analyst and commentator rather than an evangelist for products. His writings embody discussions concerning the evaluation, control, and application of artificial intelligence within the healthcare context. Based on his knowledge in finance, data science, and healthcare technology, his writing serves as an addition to discussions concerning the appropriate application of AI within medicine.
